Introduction from Quell Therapeutics, CEO, Iain McGill

Iain McGill introduces Quell Therapeutics, a leader in the new field of T-regulatory cells, and announces their planned expansion to their series A by Syncona making it the largest Series A in the space. Iain discusses Quell’s progress to date and what the financing will enable Quell to achieve.

Back to News and insights